ClinVar Miner

Submissions for variant NM_000371.4(TTR):c.69G>A (p.Thr23=)

gnomAD frequency: 0.00001  dbSNP: rs752579437
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000828910 SCV000970615 likely benign not provided 2018-03-27 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV002372375 SCV002668082 uncertain significance Cardiovascular phenotype 2022-07-19 criteria provided, single submitter clinical testing The c.69G>A variant (also known as p.T23T), located in coding exon 1 of the TTR gene, results from a G to A substitution at nucleotide position 69. This nucleotide substitution does not change the threonine at codon 23. However, this change occurs in the last base pair of coding exon 1, which makes it likely to have some effect on normal mRNA splicing. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002469304 SCV002766021 uncertain significance not specified 2022-11-12 criteria provided, single submitter clinical testing
Invitae RCV002538272 SCV003265043 uncertain significance Familial amyloid neuropathy 2022-07-15 criteria provided, single submitter clinical testing This sequence change affects codon 23 of the TTR mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the TTR protein. This variant also falls at the last nucleotide of exon 1, which is part of the consensus splice site for this exon. This variant is present in population databases (rs752579437, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with TTR-related conditions. ClinVar contains an entry for this variant (Variation ID: 669808). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.